ELDN: Eledon Pharmaceuticals Inc. Sotuvga nisbatan narx
Eledon Pharmaceuticals qimmatga tushadigan yakuniy bosqich sinovlari tufayli naqd pul yetishmovchiligiga duch kelmoqda. Shunga qaramay, tibbiyot hamjamiyati kompaniyani transplantologiya sohasidagi inqilobiy ishlanmalari uchun qadrlaydi. ESG tamoyillari va tadqiqot etikasi rivojlanish strategiyasini to'ldiradi. Daromad ko'paytirgichi bozor kutuvlarini aks ettiradi, bunda ko'rsatkich ga yetgan bo'lib, bu joriy biznes baholashini tahlil qilishga yordam beradi.
Eledon (ELDN) kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Eledon Pharmaceuticals|ELDN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Eledon Pharmaceuticals, Inc|ELDN - Kompaniya qarzlari|Balans qiymatiga qarzlar Eledon|ELDN - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Eledon Pharmaceuticals|Oraliq qoplash koeffitsiyenti eledon.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
ELDN - Kompaniyaning sof foydasi|Forvard foyda Eledon Pharmaceuticals|ELDN - P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori Eledon Pharmaceuticals Inc.|ELDN - PEG multiplikatori|EV/EBITDA multiplikatori Eledon|ELDN - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Eledon Pharmaceuticals|ELDN - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi eledon.com|ELDN - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Eledon Pharmaceuticals
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning fundamental tahlili:ELDN - eledon.com
Tebranishlar davrida kapitalni himoya qilish uchun investor bozor kapitalizatsiyasining yillik daromadga nisbatidan foydalanadi, bu esa aktivlarning haqiqiy pul oqimiga nisbatan haddan tashqari qimmat baholanganligini aniqlash imkonini beradi. Sotuvlar nisbatini tahlil qilish Eledon Pharmaceuticals (ELDN) sog'liqni saqlash gigantining biznes samaradorligini baholashga yordam beradi, bunda ekologik laboratoriyalarni modernizatsiya qilish xarajatlari va immunologik ishlanmalar doirasida filtratsiya tizimlarini joriy etish hisobga olinadi.
Eledon Pharmaceuticals raqobatchilari
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA Bio - P/S multiplikatori|Sotuvga nisbatan narx Protagonist Corp|Immunovant, Inc. (IMVT) - Narxning daromadga nisbati|KNSA (kiniksa.com) - Narxning daromadga nisbati|GRFS (Grifols) - P/S multiplikatori|Sotuvga nisbatan narx Adaptive Biotech ADPT|P/S multiplikatori CLDX|Aurinia Corp - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati BioCryst BCRX|veratx.com (VERA) - Sotuvga nisbatan narx|DNTH - Narxning daromadga nisbati|PHVS (Pharvaris NV) - Kapitalizatsiya va daromad nisbati|ABCL (AbCellera Biologics Inc) - Kapitalizatsiyaning daromadga nisbati|Tourmaline - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Precigen, Inc.|pharming.com - Narxning sotuvga nisbati|P/S multiplikatori NKTR|UPB (Upstream Bio, Inc.) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ZBIO (Zenas Biopharma, Inc.)|P/S multiplikatori Immunome Bio IMNM|GOSS - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati KALV (kalvista.com)|Septerna (SEPN) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Pieris Pharma|SVRA (Savara Corp) - P/S multiplikatori|P/S multiplikatori Rigel Corp|P/S multiplikatori ANAB|Kapitalizatsiyaning daromadga nisbati astriatx.com ATXS|P/S multiplikatori ENGN (enGene)|RAPT Therapeutics Inc. (RAPT) - Sotuvga nisbatan narx|JBIO: Kapitalizatsiyaning daromadga nisbati|ACRS - P/S multiplikatori|KYTX (Kyverna Therapeutics) - Kapitalizatsiyaning daromadga nisbati|TLSA: Kapitalizatsiyaning sotish hajmiga nisbati|CABA (Cabaletta Bio) - P/S multiplikatori|Ventyx Biosciences Inc. (VTYX) - Narx/daromad koeffitsiyenti|P/S multiplikatori THTX|Kapitalizatsiyaning daromadga nisbati Avalo Therapeutics Inc AVTX|P/S multiplikatori AGEN (Agenus)|P/S multiplikatori climbbio.com CLYM|ZURA - Narxning daromadga nisbati|ATYR: Narxning daromadga nisbati|adagene.com (ADAG) - Narxning daromadga nisbati|IMA - Narx/daromad koeffitsiyenti|STTK (Shattuck Labs Inc) - P/S multiplikatori|Sotuvga nisbatan narx Equillium Bio EQ|Narxning daromadga nisbati Connect Biopharma (CNTB)|Narxning daromadga nisbati IMUX (immunic-therapeutics.com)|P/S multiplikatori ATRA (Atara Bio)|IFRX: Kapitalizatsiya va daromad nisbati|XFOR - Narxning daromadga nisbati|ACET (Adicet Bio) - Kapitalizatsiya va daromad nisbati|celularity.com (CELU) - Narxning daromadga nisbati|Narxning sotuvga nisbati INMB (INmune Bio Inc)|BRNS (Barinthus Bio) - P/S multiplikatori|KZR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori SABS|P/S multiplikatori akaritx.com (AKTX)|Narxning daromadga nisbati Enlivex Therapeutics Ltd. ENLV|Bozor kapitallashuvining daromadga nisbati QTTB|GOVX - Narxning daromadga nisbati|Edesa Biotech Corp (EDSA) - Kapitalizatsiyaning daromadga nisbati|IBIO: P/S multiplikatori|Carisma Therapeutics Inc. (CARM) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati XTLB|BOLT: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori HCWB|Narx/daromad koeffitsiyenti aptevotherapeutics.com|Narxning daromadga nisbati AIM ImmunoTech Inc. AIM|ADTX - Kapitalizatsiyaning daromadga nisbati|GRI - Narxning daromadga nisbati|XORTX Therapeutics Inc (XRTX) - Kapitalizatsiyaning daromadga nisbati|HIND (ReShape Lifesciences) - Kapitalizatsiyaning daromadga nisbati|Revelation Biosciences Corp (REVB) - P/S multiplikatori|Narxning daromadga nisbati Indaptus Therapeutics|Kapitalizatsiya va daromad nisbati SCNI (scinai.com)|P/S multiplikatori CALI|AFMD - Sotuvga nisbatan narx|P/S multiplikatori ALLK (Allakos)|HOOKIPA Pharma, Inc. (HOOK) - Sotuvga nisbatan narx|IGMS - Narxning daromadga nisbati|ITOS: Narxning daromadga nisbati|OCEA: P/S multiplikatori|Sotuvga nisbatan narx TC BioPharm (Holdings) Plc (TCBP)|THRD (Third Harmonic Bio, Inc) - P/S multiplikatori
